Genomic and phylogenetic characterization of coxsackievirus B2 prototype strain Ohio-1

Baekkeskov, 1990, Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase, Nature, 347, 151, 10.1038/347151a0 Bergelson, 1995, Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55), J. Virol., 69, 1903, 10.1128/JVI.69.3.1903-1906.1995 Bertioli, 1997, Rapid amplification of cDNA ends, 67, 233 Chapman, 1997, Genetics of coxsackievirus virulence, 223, 227 Dalldorf, 1959, The coxsackie virus group, 519 Druyts-Voets, 1997, Epidemiological features of entero non-poliovirus isolation in Belgium 1980–94, Epidemiol. Infect., 119, 71, 10.1017/S0950268897007656 Dumas Milne Edwards, 1997, Anchoring a defined sequence to the 5' ends of mRNA, 67, 261 Gorbalenya, 1989, Cystein proteases of positive strand RNA viruses and chymotrypsin-like serine proteases, FEBS Lett., 243, 103, 10.1016/0014-5793(89)80109-7 Hierholzer, 1996, Quantitation of virus, 35 Huttunen, 1996, the major echovirus group is genetically coherent and related to coxsackie B viruses, J. Gen. Virol., 77, 715, 10.1099/0022-1317-77-4-715 Hyypiä, 1997, Classification of enteroviruses based on molecular and biological properties, J. Gen. Virol., 78, 1, 10.1099/0022-1317-78-1-1 Klump, 1990, Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: Two initial 5′ uridine residues are regained during plus strand synthesis, J. Virol., 64, 1573, 10.1128/JVI.64.4.1573-1583.1990 Koonin, 1991, The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses, J. Gen. Virol., 72, 2197, 10.1099/0022-1317-72-9-2197 Lindberg, 1992, Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3, Virus Res., 24, 187, 10.1016/0168-1702(92)90006-U Lindberg, 1997, Amplification and cloning of complete enterovirus genomes by long distance PCR, J. Virol. Methods, 65, 191, 10.1016/S0166-0934(97)02178-2 McPhee, 1994, Characterization of the N-terminal part of the neutralizing antigenic site I of coxsackievirus B4 by mutation analysis of antigen chimeras, Virus Res., 34, 139, 10.1016/0168-1702(94)90096-5 Melnick, 1996, Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, 655 Melnick, 1950, Ohio strains of virus pathogenic for infant mice (coxsackie group), simultaneous occurrence with poliomyelitis virus in patients with ‘summer grippe’, J. Exp. Med., 91, 185, 10.1084/jem.91.2.185 Minor, 1985, Growth, assay and purification of picornaviruses, 25 Minor, 1986, Antigenic structure of poliovirus of serotypes 1, 2 and 3, J. Gen. Virol., 67, 1283, 10.1099/0022-1317-67-7-1283 Muckelbauer, 1995, The structure of coxsackievirus B3 at 3.5 Å resolution, Structure, 3, 653, 10.1016/S0969-2126(01)00201-5 Page, 1988, Three-dimensional structure of poliovirus serotype 1 neutralizing determinants, J. Gen. Virol., 62, 1781, 10.1128/JVI.62.5.1781-1794.1988 Page, 1996, TREEVIEW: An application to display phylogenetic trees on personal computers, Comp. Appl. Biosci., 12, 357 Pallansch, 1997, Coxsackievirus B epidemiology and public health concerns, 223, 13 Pulli, 1995, Molecular comparison of coxsackie A virus serotypes, Virology, 212, 30, 10.1006/viro.1995.1450 Pöyry, 1994, Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses, Virology, 202, 982, 10.1006/viro.1994.1423 Pöyry, 1996, Genetic and phylogenetic clustering of enteroviruses, J. Gen. Virol., 77, 1699, 10.1099/0022-1317-77-8-1699 Reagan, 1984, Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells, J. Virol., 49, 635, 10.1128/JVI.49.3.635-640.1984 Reimann, 1991, Mapping of a neutralizing antigenic site of coxsackievirus B4 by construction of an antigen chimera, J. Virol., 65, 3475, 10.1128/JVI.65.7.3475-3480.1991 Roivainen, 1998, Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM, J. Med. Virol., 56, 74, 10.1002/(SICI)1096-9071(199809)56:1<74::AID-JMV12>3.0.CO;2-W Rueckert, 1996, Picornaviridae: the viruses and their replication, 609 Shafren, 1995, Coxsackievirus B1, B3 and B5 use decay accelerating factor as a receptor for cell attachment, J. Virol., 69, 3873, 10.1128/JVI.69.6.3873-3877.1995 Sherry, 1986, Use of monoclonal antibodies to identify four neutralizing immunogens on a common cold picornavirus, human rhinovirus 14, J. Virol., 57, 246, 10.1128/JVI.57.1.246-257.1986 Sherry, 1985, Evidence for at least two dominant neutralization antigens on human rhinovirus 14, J. Virol., 53, 137, 10.1128/JVI.53.1.137-143.1985 Thompson, 1997, The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools, Nucleic Acids Res., 25, 4876, 10.1093/nar/25.24.4876 Thompson, 1994, CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice, Nucleic Acids Res., 22, 4673, 10.1093/nar/22.22.4673 Vreugdenhil, 1998, Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule, Diabetologica, 41, 40, 10.1007/s001250050864